VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
LICNLichen International Limited
$2.17$613776
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

LICN logoLichen International Limited(LICN)Earnings, Financials & Key Ratios

LICN•NASDAQ
Price updated Jun 19, 2026
SectorIndustrialsIndustryBusiness ServicesSub-IndustryProfessional Advisory and Compliance Services
AboutLichen International Ltd. engages in providing financial and taxation solutions. It also offers educational support, and software and maintenance services. The company was founded by Li Ya on April 13, 2016 and is headquartered in Jinjiang, China.Show more
  • Revenue$41M+4.3%
  • EBITDA-$2M-112.9%
  • Net Income-$6M-173.6%
  • EPS (Diluted)-0.41-100.6%
  • Gross Margin61.9%+1.2%
  • EBITDA Margin-4.04%-112.3%
  • Operating Margin-10.97%-135.6%
  • Net Margin-14.8%-170.6%
  • ROE-8.96%-155.1%

LICN Key Insights

Lichen International Limited (LICN) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Share count reduced 43.9% through buybacks
  • ✓Healthy 5Y average net margin of 15.0%
  • ✓Trading at only 0.4x book value

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 6 (bottom 6%)
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when LICN posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

LICN Price & Volume

Lichen International Limited (LICN) stock price & volume — 10-year historical chart

Loading chart...

LICN Growth Metrics

Lichen International Limited (LICN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years5.59%
3 Years6.54%
TTM18.69%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-166.71%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-6035.76%

Return on Capital

10 Years46.68%
5 Years22.75%
3 Years14.83%
Last Year-6.64%

LICN Peer Comparison

Lichen International Limited (LICN) competitors in Professional Advisory and Compliance Services — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
FEDU logoFEDUFour Seasons Education (Cayman) Inc.Direct Competitor2.09M9.8617.55100.15%0.32%0.16%0.19
COE logoCOE51Talk Online Education GroupDirect Competitor1.55M15.62-0.0989.09%-16.46%
GOTU logoGOTUGaotu Techedu Inc.Direct Competitor598.53M1.65-13.2834.99%-5.26%-20.84%0.47
TAL logoTALTAL Education GroupProduct Competitor621.37M9.197.2951.22%6.45%4.72%0.09
EDU logoEDUNew Oriental Education & Technology Group Inc.Product Competitor7.16B45.0219.5713.6%7.37%9.09%0.20
DAO logoDAOYoudao, Inc.Product Competitor1.42B12.0590.535.03%1.82%
IQ logoIQiQIYI, Inc.Product Competitor983.6M1.02-32.84-87.01%-0.77%-0.22%1.17
BIDU logoBIDUBaidu, Inc.Supply Chain38.01B111.7664.26-3.04%3.48%0.21%0.34

Compare LICN vs Peers

Lichen International Limited (LICN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs FEDU

Most directly comparable listed peer for LICN.

Scale Benchmark

vs BIDU

Larger-name benchmark to compare LICN against a more recognizable public peer.

Peer Set

Compare Top 5

vs FEDU, COE, GOTU, TAL

LICN Income Statement

Lichen International Limited (LICN) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'15Dec'16Dec'17Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Sales/Revenue
14.76M20.78M25.58M31.6M30.67M34.3M33.8M39.76M41.48M79.57M
Revenue Growth %
59.3%40.78%23.09%23.54%-2.96%11.83%-1.43%17.61%4.32%18.69%
Cost of Goods Sold
4.23M5.61M7.35M12.26M11.83M13.82M13.61M15.44M15.8M32.81M
COGS % of Revenue
28.66%26.98%28.72%38.79%38.58%40.3%40.27%38.83%38.1%-
Gross Profit
10.53M▲ 0%
15.17M▲ 44.1%
18.24M▲ 20.2%
19.34M▲ 6.1%
18.84M▼ 2.6%
20.48M▲ 8.7%
20.19M▼ 1.4%
24.32M▲ 20.4%
25.67M▲ 5.6%
46.76M▲ 0%
Gross Margin %
71.34%73.02%71.28%61.21%61.42%59.7%59.73%61.17%61.9%58.77%
Gross Profit Growth %
70.04%44.07%20.17%6.07%-2.62%8.7%-1.38%20.44%5.57%-
Operating Expenses
5.14M6.55M8.93M9.62M10.05M9.18M9.54M12.06M30.23M47.14M
OpEx % of Revenue
34.82%31.5%34.91%30.42%32.77%26.76%28.23%30.34%72.87%-
Selling, General & Admin
4.74M6.15M8.31M9.62M10.05M9.18M9.54M12.06M30.23M47.15M
SG&A % of Revenue
32.14%29.59%32.49%30.42%32.77%26.76%28.23%30.34%72.87%-
Research & Development
396.65K397.38K620.13K0930K1.08M1.06M1.19M1.38M2.57M
R&D % of Revenue
2.69%1.91%2.42%-3.03%3.15%3.14%2.99%3.33%-
Other Operating Expenses
0000-930K-1.08M-1.06M-1.19M-1.38M-2M
Operating Income
5.39M▲ 0%
8.63M▲ 60.0%
9.3M▲ 7.8%
9.73M▲ 4.5%
8.79M▼ 9.7%
11.3M▲ 28.6%
10.65M▼ 5.8%
12.26M▲ 15.1%
-4.55M▼ 137.1%
-391K▲ 0%
Operating Margin %
36.52%41.52%36.37%30.78%28.65%32.94%31.5%30.83%-10.97%-0.49%
Operating Income Growth %
119.41%60.03%7.84%4.55%-9.67%28.58%-5.75%15.13%-137.12%-
EBITDA
5.59M8.93M9.76M11.92M9.59M13.75M11.35M13.01M-1.68M4.67M
EBITDA Margin %
37.89%42.98%38.16%37.71%31.28%40.09%33.57%32.73%-4.04%5.86%
EBITDA Growth %
119.29%59.71%9.27%22.09%-19.51%43.31%-17.45%14.65%-112.88%-76.24%
D&A (Non-Cash Add-back)
202.06K305.26K457.22K2.19M806K2.45M701K753K2.88M5.06M
EBIT
5.42M8.65M9.36M9.78M8.79M11.3M10.65M12.26M-4.55M-391K
Net Interest Income
0000103K28K60K38K163K189K
Interest Income
11.61K17.76K31.52K49K103K28K60K38K163K189K
Interest Expense
00049K000000
Other Income/Expense
28.96K23.93K59.18K5K209K216K94K-671K379K-3.44M
Pretax Income
5.42M▲ 0%
8.65M▲ 59.6%
9.36M▲ 8.2%
9.73M▲ 3.9%
9M▼ 7.6%
11.51M▲ 28.0%
10.74M▼ 6.7%
11.59M▲ 7.9%
-4.17M▼ 136.0%
-3.83M▲ 0%
Pretax Margin %
36.72%41.63%36.6%30.8%29.33%33.57%31.78%29.15%-10.06%-4.81%
Income Tax
1.46M2.42M2.86M2.66M2.59M3.05M2.92M3.25M1.95M4.49M
Effective Tax Rate %
26.95%27.97%30.53%27.36%28.78%26.51%27.22%28.05%-46.69%-117.2%
Net Income
3.96M▲ 0%
5.82M▲ 46.8%
6.51M▲ 11.8%
7.07M▲ 8.7%
6.41M▼ 9.4%
8.46M▲ 32.1%
7.82M▼ 7.6%
8.34M▲ 6.7%
-6.14M▼ 173.6%
-8.51M▲ 0%
Net Margin %
26.85%28%25.43%22.37%20.89%24.67%23.13%20.97%-14.8%-10.7%
Net Income Growth %
117.43%46.82%11.8%8.68%-9.38%32.07%-7.61%6.65%-173.63%-166.71%
Net Income (Continuing)
3.96M6.23M6.51M7.07M6.41M8.46M7.82M8.34M-6.12M-8.32M
Discontinued Operations
0000000000
Minority Interest
-4.62K00000002.38M0
EPS (Diluted)
0.14▲ 0%
0.20▲ 42.9%
0.23▲ 15.0%
0.25▲ 8.7%
0.22▼ 12.0%
0.29▲ 31.8%
69.49▲ 23862.1%
63.96▼ 8.0%
-0.41▼ 100.6%
-30.10▲ 0%
EPS Growth %
122.22%42.86%15%8.7%-12%31.82%23862.07%-7.96%-100.64%-6035.76%
EPS (Basic)
0.140.200.230.250.220.2969.4963.96-0.41-
Diluted Shares Outstanding
28.75M28.75M28.75M28.75M28.75M28.75M22.5M26.51M14.87M282.85K
Basic Shares Outstanding
28.75M28.75M28.75M28.75M28.75M28.75M22.5M26.51M14.87M282.85K
Dividend Payout Ratio
-51.73%-102.52%67.86%-----

LICN Balance Sheet

Lichen International Limited (LICN) balance sheet — assets, liabilities & shareholders' equity

MetricDec'15Dec'16Dec'17Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Total Current Assets
10.7M12.62M10.84M7.42M11.65M23.89M27.27M40.13M34.01M28.32M
Cash & Short-Term Investments
1.72M4.62M5.01M5.39M8.66M16.84M22.6M25.86M26.71M22.57M
Cash Only
1.72M4.62M5.01M5.39M8.66M16.84M22.6M25.86M26.71M22.57M
Short-Term Investments
0000000000
Accounts Receivable
4.24M2.47M2.39M1.88M2.83M4.36M3.54M4.46M7.09M2.13M
Days Sales Outstanding
104.9443.3934.0621.7233.7246.4138.2840.9762.4319.09
Inventory
49.13K34.25K38.7K33K23K150K127K87K67K0
Days Inventory Outstanding
4.242.231.920.980.713.963.412.061.550.58
Other Current Assets
4.62M5.47M3.38M118K48K2.24M46K5.72M74K3.43M
Total Non-Current Assets
779.23K2.11M11.01M21.37M21.7M19.05M19.26M25.41M45.83M38.88M
Property, Plant & Equipment
387.77K1.19M10.26M15.46M15.77M14.94M13.5M14.76M13.75M7.31M
Fixed Asset Turnover
38.07x17.53x2.49x2.04x1.94x2.30x2.50x2.69x3.02x6.36x
Goodwill
000000004.45M4.45M
Intangible Assets
0005.51M5.59M3.87M4.52M6.03M11.05M9.51M
Long-Term Investments
00000000145K1.33M
Other Non-Current Assets
391.46K923.66K743.55K401K337K250K1.24M4.63M16.43M16.42M
Total Assets
11.48M▲ 0%
14.73M▲ 28.2%
21.85M▲ 48.4%
28.79M▲ 31.8%
33.35M▲ 15.8%
42.94M▲ 28.8%
46.52M▲ 8.3%
65.55M▲ 40.9%
79.84M▲ 21.8%
67.21M▲ 0%
Asset Turnover
1.29x1.41x1.17x1.10x0.92x0.80x0.73x0.61x0.52x1.12x
Asset Growth %
127.21%28.23%48.37%31.77%15.83%28.77%8.34%40.88%21.81%84.46%
Total Current Liabilities
3.09M3.82M3.28M5.07M5.71M6.11M5.23M4.09M4.27M2.78M
Accounts Payable
42.35K108.35K46.38K85K95K123K161K61K55K0
Days Payables Outstanding
3.657.052.32.532.933.254.321.441.270.54
Short-Term Debt
000315K337K345K88K0078K
Deferred Revenue (Current)
0001.18M1.1M1.27M1.15M1.03M696K2.58M
Other Current Liabilities
3.05M3.72M3.23M3.41M3.57M3.77M3.75M1.68M150K412K
Current Ratio
3.46x3.30x3.31x1.47x2.04x3.91x5.21x9.81x7.96x10.19x
Quick Ratio
3.45x3.29x3.30x1.46x2.04x3.88x5.19x9.79x7.95x10.19x
Cash Conversion Cycle
105.5338.5733.6820.1831.547.1337.3641.5962.719.12
Total Non-Current Liabilities
000001.74M184K34K5K176K
Long-Term Debt
0000000000
Capital Lease Obligations
000000184K34K5K223K
Deferred Tax Liabilities
0000000000
Other Non-Current Liabilities
0000000000
Total Liabilities
3.09M3.82M3.28M5.07M5.71M6.11M5.42M4.13M4.28M2.96M
Total Debt
000315K337K345K272K129K61K357K
Net Debt
-1.72M-4.62M-5.01M-5.08M-8.33M-16.5M-22.33M-25.73M-26.65M-22.22M
Debt / Equity
---0.01x0.01x0.01x0.01x0.00x0.00x0.01x
Debt / EBITDA
---0.03x0.04x0.03x0.02x0.01x-0.08x
Net Debt / EBITDA
-0.31x-0.52x-0.51x-0.43x-0.87x-1.20x-1.97x-1.98x--4.76x
Interest Coverage
---199.63x------
Total Equity
8.39M▲ 0%
10.9M▲ 29.9%
18.57M▲ 70.4%
23.73M▲ 27.8%
27.64M▲ 16.5%
36.83M▲ 33.2%
41.11M▲ 11.6%
61.42M▲ 49.4%
75.56M▲ 23.0%
64.25M▲ 0%
Equity Growth %
124.3%29.88%70.37%27.75%16.51%33.24%11.61%49.41%23.03%95.49%
Book Value per Share
0.290.380.650.830.961.281.832.325.08227.16
Total Shareholders' Equity
8.4M10.9M18.57M23.73M27.64M36.83M41.11M61.42M73.18M64.25M
Common Stock
01441541K1K1K1K1K4K6K
Retained Earnings
6.25M7.42M14.67M22.49M24.55M33.01M40.83M48.22M42.08M34.46M
Treasury Stock
0000000000
Accumulated OCI
2.15M2.14M2.47M-256K1.6M2.33M-1.21M-1.7M-2.26M-3.84M
Minority Interest
-4.62K00000002.38M0

LICN Cash Flow Statement

Lichen International Limited (LICN) cash flow — operating, investing & free cash flow history

MetricDec'15Dec'16Dec'17Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Cash from Operations
3.72M8.8M6.36M13.57M8.35M7.3M10.77M557K-5.57M-6.74M
Operating CF Margin %
25.18%42.33%24.88%42.94%27.23%21.3%31.85%1.4%-13.43%-
Operating CF Growth %
195.04%136.71%-27.66%113.21%-38.46%-12.53%47.4%-94.83%-1100.36%1376.5%
Net Income
3.96M5.82M6.51M7.07M6.41M8.46M7.82M8.34M-6.12M-8.51M
Depreciation & Amortization
202.06K305.26K457.22K2.19M2.16M2.45M2.68M2.92M2.88M5.28M
Stock-Based Compensation
000000003.41M1.01M
Deferred Taxes
0000000000
Other Non-Cash Items
2.31M526.98K-604.74K-5K87K63K50K72K109K6.44M
Working Capital Changes
-899.74K1.38M460.33K4.31M-304K-3.67M217K-10.78M-5.85M-10.96M
Change in Receivables
-2.88M1.27M136.43K-2.36M-465K-1.45M66K-982K642K1.07M
Change in Inventory
-14.32K12.19K-2.07K3K11K-126K11K38K19K130K
Change in Payables
1.44M100.4K325.97K64K4K25K51K-98K-4K15K
Cash from Investing
-4.9M-2.96M-6.53M-10.83M-1.16M561K-2.84M-9.87M-9.89M-12.51M
Capital Expenditures
-122.99K-1.76M-4.46M-10.83M-1.16M-28K-2.84M-5.27M-36K-2.33M
CapEx % of Revenue
0.83%8.45%17.42%34.26%3.78%0.08%8.41%13.25%0.09%2.93%
Acquisitions
04.52K000589K00-3.96M-2.41M
Investments
----------
Other Investing
-4.77M-1.2M-2.07M0000-4.6M-5.9M-7.77M
Cash from Financing
2.3M-2.66M244K-8.99M-4.35M0-327K14.1M13.09M18.18M
Debt Issued (Net)
000000-327K000
Equity Issued (Net)
1.02M00000014.1M12.22M18.1M
Dividends Paid
0-3.01M0-7.25M-4.35M00000
Share Repurchases
0000000000
Other Financing
1.28M346.5K244K-1.74M0000866K78K
Net Change in Cash
1.12M▲ 0%
2.9M▲ 158.9%
390.18K▼ 86.6%
376.18K▼ 3.6%
3.27M▲ 770.6%
8.18M▲ 149.8%
5.75M▼ 29.7%
3.26M▼ 43.4%
856K▼ 73.7%
26.09M▲ 0%
Free Cash Flow
3.59M▲ 0%
7.04M▲ 95.9%
1.91M▼ 72.9%
2.74M▲ 43.6%
7.19M▲ 162.3%
7.28M▲ 1.2%
7.92M▲ 8.9%
-2.65M▼ 133.4%
-11.51M▼ 334.6%
-9.07M▲ 0%
FCF Margin %
24.34%33.88%7.46%8.67%23.45%21.22%23.44%-6.66%-27.74%-11.4%
FCF Growth %
815.02%95.94%-72.9%43.62%162.31%1.2%8.91%-133.4%-334.64%-231.51%
FCF per Share
0.120.240.070.100.250.250.35-0.10-0.77-32.08
FCF Conversion (FCF/Net Income)
0.94x1.51x0.98x1.92x1.30x0.86x1.38x0.07x0.91x1.07x
Interest Paid
000015K15K1K000
Taxes Paid
00002.31M2.98M2.96M2.63M2.41M0

LICN Key Ratios

Lichen International Limited (LICN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201520162017201920202021202220232024TTM
Return on Equity (ROE)
65.32%60.32%44.15%33.43%24.95%26.25%20.06%16.26%-8.96%-12.57%
Return on Invested Capital (ROIC)
82.95%99.95%70.37%45.31%34.72%42.74%40.83%33.76%-8.07%-0.72%
Gross Margin
71.34%73.02%71.28%61.21%61.42%59.7%59.73%61.17%61.9%58.77%
Net Margin
26.85%28%25.43%22.37%20.89%24.67%23.13%20.97%-14.8%-10.7%
Debt / Equity
---0.01x0.01x0.01x0.01x0.00x0.00x0.01x
Interest Coverage
---199.63x------
FCF Conversion
0.94x1.51x0.98x1.92x1.30x0.86x1.38x0.07x0.91x1.07x
Revenue Growth
59.3%40.78%23.09%23.54%-2.96%11.83%-1.43%17.61%4.32%18.69%
Related:LICN Dividend History·LICN Revenue History·LICN Price History·LICN P/E History·LICN Financial Ratios·LICN Institutional Holders

LICN Frequently Asked Questions

Lichen International Limited (LICN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Lichen International Limited (LICN) reported $79.6M in revenue for fiscal year 2024. This represents a 759% increase from $9.3M in 2014.

Lichen International Limited (LICN) grew revenue by 4.3% over the past year. Growth has been modest.

Lichen International Limited (LICN) reported a net loss of $8.5M for fiscal year 2024.

Dividend & Returns

Lichen International Limited (LICN) has a return on equity (ROE) of -9.0%. Negative ROE indicates the company is unprofitable.

Lichen International Limited (LICN) had negative free cash flow of $9.1M in fiscal year 2024, likely due to heavy capital investments.

What if you invested $1,000 in LICN back in 2014?

Total return calculator · dividends reinvested · 12+ years of data

See returns →

How much would $100/month in LICN be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →